118 related articles for article (PubMed ID: 12494213)
1. [Statin is indicated to all patients with high risk of complications of coronary heart disease irrespective of the level of low density lipoprotein cholesterol. Results of HPS].
Gratsianskiĭ NA
Kardiologiia; 2002; 42(2):84-5. PubMed ID: 12494213
[No Abstract] [Full Text] [Related]
2. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
Pedersen TR
Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
[TBL] [Abstract][Full Text] [Related]
3. Making the most of cholesterol-lowering margarines.
Avery JK
Cleve Clin J Med; 2001 Mar; 68(3):194-6. PubMed ID: 11263847
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
Kastelein JJ; Sankatsing RR
Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
[TBL] [Abstract][Full Text] [Related]
6. [Overviews of fibrate].
Tada N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
[No Abstract] [Full Text] [Related]
7. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Mikhailidis DP; Wierzbicki AS
Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011
[No Abstract] [Full Text] [Related]
8. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
[No Abstract] [Full Text] [Related]
9. Prognostic and therapeutic significance of low levels of high-density lipoprotein cholesterol: current perspectives.
Gotto AM
Arch Intern Med; 1999 May; 159(10):1038-40. PubMed ID: 10335679
[No Abstract] [Full Text] [Related]
10. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
Molcányiová A; Stancáková A; Javorský M; Tkác I
Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
[TBL] [Abstract][Full Text] [Related]
11. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
Collins R; Armitage J; Parish S; Sleight P; Peto R;
Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
[TBL] [Abstract][Full Text] [Related]
12. [Hyperlipidemia and coronary heart disease].
Brugger P
Wien Med Wochenschr; 1990 Jul; 140(14):382, 384-6. PubMed ID: 2219944
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
[TBL] [Abstract][Full Text] [Related]
14. The relationship between low-density lipoprotein cholesterol goal attainment and prevention of coronary heart disease--related events.
Ito MK; Delucca GM; Aldridge MA
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):129-35. PubMed ID: 11509919
[TBL] [Abstract][Full Text] [Related]
15. Hyperlipidaemia and cardiovascular disease.
Wray R
Curr Opin Lipidol; 1995 Dec; 6(6):U160-4. PubMed ID: 8750258
[No Abstract] [Full Text] [Related]
16. Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.
Tunceli K; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tomassini JE; Foody JM
J Clin Lipidol; 2010; 4(6):491-500. PubMed ID: 21122696
[TBL] [Abstract][Full Text] [Related]
17. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
18. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
19. [Even at LDL cholesterol 100mg/dl. "Every coronary disease patient has to receive a statin"].
MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963997
[No Abstract] [Full Text] [Related]
20. Benefits of simvastin in cholesterol lowering.
Farmer JA
Curr Atheroscler Rep; 2003 Mar; 5(2):93-4. PubMed ID: 12573191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
